Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-05

Clinical Trial Update: Letrozole and Misoprostol for Early Pregnancy Loss Management [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on the use of letrozole and misoprostol for managing early pregnancy loss, currently recruiting at the University of Pennsylvania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)
  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: University of Pennsylvania | Conditions: Early Pregnancy Loss, Miscarriage in First Trimester | Phase 2 | Status: RECRUITING